Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.

Zdroj:	Arthritis Research & Therapy; 1/23/2017, Vol. 19, p1-1, 1p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink